Skip to Content

Health

Biden administration announces deal to provide J&J Covid-19 vaccine to people in conflict zones and humanitarian settings

By Arlette Saenz, Kate Sullivan and Jennifer Hansler, CNN The Biden administration on Wednesday announced a new deal it brokered with Johnson & Johnson and the global vaccination program called Covid-19 Vaccines Global Access, or COVAX, to provide J&J’s Covid-19 vaccine to people in conflict zones and other humanitarian settings where government vaccine campaigns cannot

Continue Reading

Pfizer signs license agreement to allow broader global access to its experimental Covid-19 antiviral pill

By Amanda Sealy, CNN Pfizer said Tuesday it signed a licensing agreement to allow broader global access to its experimental Covid-19 pill. The agreement with the Medicines Patent Pool, a United Nations-backed public health organization, would allow generic manufacturers to make the pill widely available in 95 low- and middle-income countries covering 53% of the

Continue Reading

Discrimination of any kind can lead to much higher risk of mental and behavioral issues for young people, study finds

By Kristen Rogers, CNN Young adults who experience discrimination about their bodies, race, age or sex have a greater risk of dealing with mental health problems than those who do not, a new study has found. Encountering discrimination — especially racism — has long been associated with negative effects on overall well-being, such as higher

Continue Reading

Novavax to complete data submission to FDA by end of the year for authorization of its coronavirus vaccine

By Jacqueline Howard, CNN The biotechnology company Novavax plans to submit complete data to the US Food and Drug Administration soon for possible emergency use authorization of its coronavirus vaccine, CEO Stanley Erck told CNN in a phone interview Friday. “We’ll have a file in the US hopefully before the end of the year,” Erck

Continue Reading

Even if they get breakthrough infections, vaccinated people don’t get as sick with Covid-19, studies show

By Maggie Fox, CNN Even if they get a breakthrough infection, vaccinated people don’t get as sick with Covid-19, two different teams of researchers reported Thursday. Both studies show the vaccines strongly protect against severe disease and death, even months after people were first vaccinated and as the more transmissible Delta variant renewed the spread

Continue Reading

Even if they get breakthrough infections, vaccinated people don’t get as sick with Covid-19, studies show

By Maggie Fox, CNN Even if they get a breakthrough infection, vaccinated people don’t get as sick with Covid-19, two different teams of researchers reported Thursday. Both studies show the vaccines strongly protect against severe disease and death, even months after people were first vaccinated and as the more transmissible Delta variant renewed the spread

Continue Reading

Vaccine rule for larger employers, federal contractors and certain health care workers to take effect January 4

By Jason Hoffman, CNN The Biden administration announced Thursday that its vaccine rules applying to private businesses with 100 or more employees, certain health care workers and federal contractors will take effect January 4. The rules stipulate that employees that fall into those groups will need to have received the necessary shots to be fully

Continue Reading

UK becomes first to authorize Merck and Ridgeback Biotherapeutics’ antiviral molnupiravir to treat mild-to-moderate Covid-19

By Jamie Gumbrecht, CNN The UK Medicines and Healthcare Products Regulatory Agency said Thursday it had authorized Merck and Ridgeback Biotherapeutics’ oral antiviral, molnupiravir, to treat mild-to-moderate Covid-19 in adults at risk for severe illness. It is the world’s first oral antiviral to be authorized anywhere for the treatment of Covid-19. The drug comes in

Continue Reading

Pediatrician or pharmacy? Expert weighs in on how to get a Covid vaccine appointment for your child

By Madeline Holcombe, CNN Now that health officials in the US have issued emergency use authorization for a vaccine for younger children, the next step in vaccinating children is families finding the nearest dose. The US Centers for Disease Control and Prevention recommended Tuesday that children ages 5 to 11 get a version of Pfizer-BioNTech’s

Continue Reading